Published by Michele Maatouk on 8th March 2022
(Sharecast News) - Clinical stage biotechnology company Destiny Pharma said on Tuesday that it was looking to raise up to £7m in a conditional fundraising to continue progress towards Phase 3 in its two lead clinical assets.
URL: http://www.digitallook.com/dl/news/story/32515876/...